GETI-B:STO
Getinge publ AB
252,30 SEK
arrow_upward
+0,96%(+2,40) 1K
6-okt, 11:30:31 (GMT+2) · SEK
search
Barcha belgilar
| Belgi | Narxi | Oʻzgartirishlar | Dinamika (%) |
|---|
insights_autoGETI-B tikeri uchun statistika yaratilmoqda...
Ochish
248,00 SEK
Yuqori
252,80 SEK
Past
243,90 SEK
Bozor kapitali
64,12 mlrd
Oʻrtacha hajm
578,49 ming
Hajmi
205,37 ming
Dividend
1,88%
Choraklik dividendlar
1,19 SEK
Eks-dividend sanasi
22-apr, 2026
P/E koeffitsiyenti
25,70
52 haftalik eng yuqori
252,80 SEK
52 haftalik eng past
175,90 SEK
Aksiya boʻyicha daromad
9,82 SEK
Muomaladagi aksiyalar
254,15 mln
Xodimlar soni
12 ming
Ochish
248,00 SEK
Yuqori
252,80 SEK
Past
243,90 SEK
Bozor kapitali
64,12 mlrd
Oʻrtacha hajm
578,49 ming
Hajmi
205,37 ming
Dividend
1,88%
Choraklik dividendlar
1,19 SEK
Eks-dividend sanasi
22-apr, 2026
P/E koeffitsiyenti
25,70
52 haftalik eng yuqori
252,80 SEK
52 haftalik eng past
175,90 SEK
Aksiya boʻyicha daromad
9,82 SEK
Muomaladagi aksiyalar
254,15 mln
Xodimlar soni
12 ming
Yangiliklar
Internet manbalari va yangilik hamkorlarimizdan
AD HOC NEWS
·
18 soat oldin
Analysts lift fair value for Getinge stock to SEK 251.70
Profil
Getinge AB is a publicly traded Swedish medical technology company. The company produces and distributes medical products and equipment for the healthcare and life sciences industries. The company is divided into three business areas: Life Science, Acute Care Therapies, and Surgical Workflows. The group employs approximately 12,000 people worldwide. The CEO of the company is Mattias Perjos, and the chairman of the board is Johan Malmquist. With a sales share of around 40%, the United States is by far the most important market for the company due to significantly higher prices and margins there. China and various Western European countries follow. Wikipedia
Getinge publ AB haqida